The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Gene Review

IGKV1-33  -  immunoglobulin kappa variable 1-33

Homo sapiens

Synonyms: IGKV133, O18
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of IGKV1-33

  • Most (80%) of these E. coli K1 strains were serotyped as O7, O18, O83, or were autoagglutinable [1].
  • Monoclonal IgM specific for the O18 antigen conferred passive protection to 1-week-old rats against bacteremia and killing after oral challenge with O18:K1 Escherichia coli [2].
  • Monoclonal antibodies (MAbs) reactive with selected O antigen serotypes of Escherichia coli (O18) and Salmonella typhimurium (O9, 12), when used in the IML, were shown to be highly specific in detecting their respective endotoxins in purified form and in plasma samples from experimentally infected animals [3].
  • To study antibody-mediated protection against Escherichia coli peritonitis in BALB/c mice, monoclonal antibodies (MAbs) were generated against the capsule (K5) and the lipopolysaccharide (O18) of E. coli [4].
  • The O18 lipopolysaccharide contains a phosphocholine substitute, which makes it unique among Proteus strains [5].
 

High impact information on IGKV1-33

  • V kappa I antibodies appear to be products of three newly sequenced V kappa I genes, O8, O18, and L11, that are reported here [6].
  • A single mutation in the gene that codes for UDP N-acetylgalactosamine 4-epimerase (gne) confers the O(-) phenotype (LPS without O-antigen molecules) on a strain in serotypes O18 and O34, but not in serotypes O1 and O2 [7].
  • Serum obtained after immunization with an O18 polysaccharide-toxin A conjugate vaccine was evaluated for the estimation of protective levels of anti-O-specific lipopolysaccharide (LPS) immunoglobulin G (IgG) antibody against bacteremia and death caused by a homologous serotype of Escherichia coli K1 strains [8].
  • Colonic resident strains expressed P fimbriae, adhered to colonic epithelial cells via a mannose-resistant mechanism, and expressed the uropathogenic serotypes O1, O2, O6, O7, O18, O25, or O75 more often than did the transient strains, which were often nontypeable [9].
  • O1, O2, O6, O7, O18, O25, and rough-type lipopolysaccharide accounted for 40% of all isolates [10].
 

Chemical compound and disease context of IGKV1-33

 

Biological context of IGKV1-33

  • The O8 and O18 genes encode identical amino acid sequences [6].
  • Both conjugates engendered an immunoglobulin G antibody response in rabbits that recognized native O18 lipopolysaccharide [14].
  • However, a hybridization probe derived from a sequence adjacent to the hlyC-proximal end of the plasmid pHly 152-encoded hly determinant hybridizes with several additional chromosomal bands in hemolytic O18 and O6 E. coli strains and even in E. coli K-12 [16].
  • Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea [17].
  • S fimbriae genotypes were observed more frequently in septic (25%) and urinary (12%) isolates of E. coli than in faecal and water isolates (1%) and often occurred together with O2, O6, O18 and O83 antigens [18].
 

Anatomical context of IGKV1-33

 

Associations of IGKV1-33 with chemical compounds

  • Among strains of the eight O-types most frequently causing such infections at this hospital, O4, O9, and O18 had a high incidence of multiple resistance (35, 22, and 19%, respectively); O2 and O6 had a intermediate incidence (14 and 11%, respectively); and O7, O1, and O75 had a low incidence (8, 6, and less than 3%, respectively) [21].
  • Specific protection of the pups was also achieved by immunizing the pregnant rats with purified O18 lipopolysaccharide [2].
  • In contrast, the aerobactin system was not detected in strains from the O18 MP6 clone [13].
  • Mass spectrometric analysis enabled detection of isotopic O18 enrichment at parts per million levels in blood and in breath CO2 [22].
  • Pathogenesis studies in chickens and colostrum-deprived calves revealed that the loss of virulence exhibited by the forms of the MW strain that lacked O18, K1 and ColV and by the NTG-derived form was associated with decreased ability to invade the body [23].
 

Analytical, diagnostic and therapeutic context of IGKV1-33

  • Sera from normal healthy human adults and infants, as well as sera from mice, rabbits, and guinea pigs, were examined by immunoblotting for naturally occurring antibodies reacting with outer membrane proteins of two Escherichia coli strains, O111 and O18 [24].
  • RESULTS: Sequence analysis of CG1 revealed that its heavy and light chain V regions were respectively most homologous to the 3d279d VH4 and the O18 Vk1 genes [19].

References

  1. Neonatal meningitis caused by Escherichia coli in The Netherlands. Mulder, C.J., van Alphen, L., Zanen, H.C. J. Infect. Dis. (1984) [Pubmed]
  2. Antibodies to O-antigen of lipopolysaccharide are protective against neonatal infection with Escherichia coli K1. Pluschke, G., Achtman, M. Infect. Immun. (1985) [Pubmed]
  3. Detection of enterobacterial lipopolysaccharides and experimental endotoxemia by means of an immunolimulus assay using both serotype-specific and cross-reactive antibodies. Saxen, H., Vuopio-Varkila, J., Luk, J., Lindberg, A., Lang, A., Di Padova, F., Cryz, S.J., Mertsola, J., McCracken, G.H., Hansen, E.J. J. Infect. Dis. (1993) [Pubmed]
  4. Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice. Frasa, H., Benaissa-Trouw, B., Tavares, L., van Kessel, K., Poppelier, M., Kraaijeveld, K., Verhoef, J. Infect. Immun. (1996) [Pubmed]
  5. Interleukin-8 response in cells from the human urinary tract induced by lipopolysaccharides of Proteus mirabilis O3 and O18. Chromek, M., Stankowska, D., Dadfar, E., Kaca, W., Rabbani, H., Brauner, A. J. Urol. (2005) [Pubmed]
  6. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous. Scott, M.G., Crimmins, D.L., McCourt, D.W., Chung, G., Schäble, K.F., Thiebe, R., Quenzel, E.M., Zachau, H.G., Nahm, M.H. J. Immunol. (1991) [Pubmed]
  7. The UDP N-acetylgalactosamine 4-epimerase gene is essential for mesophilic Aeromonas hydrophila serotype O34 virulence. Canals, R., Jiménez, N., Vilches, S., Regué, M., Merino, S., Tomás, J.M. Infect. Immun. (2006) [Pubmed]
  8. Estimation of protective levels of anti-O-specific lipopolysaccharide immunoglobulin G antibody against experimental Escherichia coli infection. Schiff, D.E., Wass, C.A., Cryz, S.J., Cross, A.S., Kim, K.S. Infect. Immun. (1993) [Pubmed]
  9. Resident colonic Escherichia coli strains frequently display uropathogenic characteristics. Wold, A.E., Caugant, D.A., Lidin-Janson, G., de Man, P., Svanborg, C. J. Infect. Dis. (1992) [Pubmed]
  10. Escherichia coli in fecal flora of healthy adults: serotypes, P and type 1C fimbriae, non-P mannose-resistant adhesins, and hemolytic activity. Siitonen, A. J. Infect. Dis. (1992) [Pubmed]
  11. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates. McCabe, W.R., Kaijser, B., Olling, S., Uwaydah, M., Hanson, L.A. J. Infect. Dis. (1978) [Pubmed]
  12. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation. Pluschke, G., Bordmann, G., Daoudaki, M.E., Lambris, J.D., Achtman, M., Neibert, M. Eur. J. Immunol. (1989) [Pubmed]
  13. Occurrence of chromosome- or plasmid-mediated aerobactin iron transport systems and hemolysin production among clonal groups of human invasive strains of Escherichia coli K1. Valvano, M.A., Silver, R.P., Crosa, J.H. Infect. Immun. (1986) [Pubmed]
  14. Synthesis and characterization of Escherichia coli O18 O-polysaccharide conjugate vaccines. Cryz, S.J., Cross, A.S., Sadoff, J.C., Fürer, E. Infect. Immun. (1990) [Pubmed]
  15. Virulence factors of Escherichia coli. II. Antigens O4, O6 and O18, haemolysin production and mannose resistant haemagglutinating capacity are closely associated. Czirók, E. Acta Microbiol. Hung. (1985) [Pubmed]
  16. Multiple copies of hemolysin genes and associated sequences in the chromosomes of uropathogenic Escherichia coli strains. Knapp, S., Hacker, J., Then, I., Müller, D., Goebel, W. J. Bacteriol. (1984) [Pubmed]
  17. Virulence properties of Escherichia coli faecal strains isolated in Poland from healthy children and strains belonging to serogroups O18, O26, O44, O86, O126 and O127 isolated from children with diarrhoea. Paciorek, J. J. Med. Microbiol. (2002) [Pubmed]
  18. Occurrence of S and F1C/S-related fimbrial determinants and their expression in Escherichia coli strains isolated from extraintestinal infections. Sokolowska-Köhler, W., Schönian, G., Bollmann, R., Schubert, A., Parschau, J., Seeberg, A., Presber, W. FEMS Immunol. Med. Microbiol. (1997) [Pubmed]
  19. Isolation of an IgG monoclonal anti-dnaJ antibody from an immunoglobulin combinatorial library from a patient with rheumatoid arthritis. Chukwuocha, R.U., Zhang, B., Lai, C.J., Scavulli, J.F., Albani, S., Carson, D.A., Chen, P.P. J. Rheumatol. (1999) [Pubmed]
  20. Escherichia coli interactions with Acanthamoeba: a symbiosis with environmental and clinical implications. Alsam, S., Jeong, S.R., Sissons, J., Dudley, R., Kim, K.S., Khan, N.A. J. Med. Microbiol. (2006) [Pubmed]
  21. Spread of R-plasmids among Escherichia coli causing urinary tract infections. Hughes, C., Bauer, E., Roberts, A.P. Antimicrob. Agents Chemother. (1981) [Pubmed]
  22. Early experiences with the stable isotope method in children. Mecrow, I., Miller, V., Preston, T. Clinical therapeutics. (1990) [Pubmed]
  23. The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity. Smith, H.W., Huggins, M.B. J. Gen. Microbiol. (1980) [Pubmed]
  24. Naturally occurring antibodies in human sera that react with the iron-regulated outer membrane proteins of Escherichia coli. Griffiths, E., Stevenson, P., Thorpe, R., Chart, H. Infect. Immun. (1985) [Pubmed]
 
WikiGenes - Universities